MRL Diagnostics has developed a dual enzyme immunoassay (EIA) system that employs the recombinant Herpes Simplex Virus (HSV) type-specific glycoproteins G1 (HSV1) and G2 (HSV2) to detect HSV typespecific IgG antibodies. This system was evaluated using 155 consecutive sera previously tested in a conv
Oncogenic transformation of primary hamster cells by herpes simplex virus type 2 (HSV-2) and an HSV-2 temperature-sensitive mutant
✍ Scribed by Susumu Kimura; Virginia L. Flannery; Barnet Levy; Priscilla A. Schaffer
- Publisher
- John Wiley and Sons
- Year
- 1975
- Tongue
- French
- Weight
- 933 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Six oncogenically transformed cell lines were obtained following infection of hamster embryo fibroblasts with UV‐irradiated herpes simplex virus type 2 (HSV‐2) or with an HSV‐2 temperature‐sensitive mutant. All lines produced undifferentiated fibrosarcomas in newborn hamsters, four of the six lines produced metastatic tumors in the lung, and sera from tumor‐bearing hamsters contained neutralizing antibody to HSV‐2. HSV‐specific cell‐surface antigen (s) was detected by immunofluorescence tests in all six of the lines established from primary tumors. Antibody to an early, HSV‐specific, non‐structural polypeptide (VP134) reacted by immunofluorescence with antigen (s) in fixed preparation of three of the six tumor‐cell lines.
📜 SIMILAR VOLUMES
## Abstract Rat embryo fibroblasts (REF) morphologically transformed by herpes simplex virus type 2 (HSV‐2) and tumor‐derived cells were tested for ability to grow in the presence of 9‐(2‐hydroxyethoxymethyl) guanine (acyclovir). Results indicated that the effective dose of acyclovir (ACV) required